1981
DOI: 10.1007/bf01309497
|View full text |Cite
|
Sign up to set email alerts
|

Serum creatine kinase isoenzymes behavior in hepatic failure with encephalopathy

Abstract: Serum creatine kinase isoenzymes were determined in 24 patients with hepatic failure. Hepatic failure was due to severe acute and chronic liver disease. The 24 patients presented different degrees of coma. Nineteen cases (seven hepatitis and 12 cirrhosis) in coma grades III and IV showed the presence in serum of BB, brain and MB, myocardial isoenzymes. Follow up in six of these cases demonstrated that worsening or improvement was accompanied by an increase or decrease of this brain isoenzyme concentration. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1983
1983
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Although CK-BB is generally absent in serum under normal conditions, it has been reported to be elevated in hepatic failure patients with encephalopathy . In addition, the blood concentration of CK-MM is increased by around 100-fold in Duchenne muscular dystrophy (DMD) patients, who show cognitive dysfunction as a major feature, , compared to that under normal conditions (around 40 ng/mL).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although CK-BB is generally absent in serum under normal conditions, it has been reported to be elevated in hepatic failure patients with encephalopathy . In addition, the blood concentration of CK-MM is increased by around 100-fold in Duchenne muscular dystrophy (DMD) patients, who show cognitive dysfunction as a major feature, , compared to that under normal conditions (around 40 ng/mL).…”
Section: Discussionmentioning
confidence: 99%
“…Although CK-BB is generally absent in serum under normal conditions, it has been reported to be elevated in hepatic failure patients with encephalopathy. 48 In addition, the blood concentration of CK-MM is increased by around 100-fold in Duchenne muscular dystrophy (DMD) patients, 49 who show cognitive dysfunction as a major feature, 10,50 compared to that under normal conditions (around 40 ng/mL). Thus, the circulating blood-to-brain transport system of CKs across the BBB is likely to have a functional impact on peripheral organto-brain communications, especially in patients with peripheral organ injuries.…”
Section: Molecular Pharmaceuticsmentioning
confidence: 99%